Selected research
Market Outlook & Growth Opportunities
Global RNA Synthesis Market Outlook and Growth Opportunities 2026
Market perspective
The global RNA Synthesis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the RNA Synthesis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the RNA Synthesis market include GenScript, Hokkaido System Science, Bio-Synthesis, IDT, Thermo Fisher Scientific, Genewiz, Gene Universal, TriLink BioTechnologies and GE Healthcare Dharmacon, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global RNA Synthesis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of RNA Synthesis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents RNA Synthesis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global RNA Synthesis market.
RNA Synthesis Segment by Company
GenScript
Hokkaido System Science
Bio-Synthesis
IDT
Thermo Fisher Scientific
Genewiz
Gene Universal
TriLink BioTechnologies
GE Healthcare Dharmacon
ChemGenes
Creative Biolabs
Glen Research
VeliterBio
Creative Biogene
Merck
Eurofins Scientific
RNA Synthesis Segment by Type
mRNA Synthesis
tRNA Synthesis
rRNA Synthesis
siRNA Synthesis
RNA Synthesis Segment by Application
Biomedical Science
Pharmaceutical
Others
RNA Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global RNA Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the RNA Synthesis key companies, revenue, market share, and recent developments.
3. To split the RNA Synthesis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions RNA Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify RNA Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze RNA Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RNA Synthesis industry.
Chapter 3: Detailed analysis of RNA Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of RNA Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of RNA Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. RNA Synthesis Industry Trends
Table 2. RNA Synthesis Industry Drivers
Table 3. RNA Synthesis Industry Opportunities and Challenges
Table 4. RNA Synthesis Industry Restraints
Table 5. Global RNA Synthesis Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global RNA Synthesis Revenue Share by Company (2021-2026)
Table 7. Global RNA Synthesis Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global RNA Synthesis Key Company Manufacturing Base & Headquarters
Table 9. Global RNA Synthesis Company, Product Type & Application
Table 10. Global RNA Synthesis Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global RNA Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of mRNA Synthesis
Table 15. Significant Companies of tRNA Synthesis
Table 16. Significant Companies of rRNA Synthesis
Table 17. Significant Companies of siRNA Synthesis
Table 18. Global RNA Synthesis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 19. Global RNA Synthesis Sales Value by Type (2021-2026) & (US$ Million)
Table 20. Global RNA Synthesis Sales Value by Type (2027-2032) & (US$ Million)
Table 21. Global RNA Synthesis Sales Value Share by Type (2021-2026)
Table 22. Global RNA Synthesis Sales Value Share by Type (2027-2032)
Table 23. Significant Companies of Biomedical Science
Table 24. Significant Companies of Pharmaceutical
Table 25. Significant Companies of Others
Table 26. Global RNA Synthesis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 27. Global RNA Synthesis Sales Value by Application (2021-2026) & (US$ Million)
Table 28. Global RNA Synthesis Sales Value by Application (2027-2032) & (US$ Million)
Table 29. Global RNA Synthesis Sales Value Share by Application (2021-2026)
Table 30. Global RNA Synthesis Sales Value Share by Application (2027-2032)
Table 31. Global RNA Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global RNA Synthesis Sales Value by Region (2021-2026) & (US$ Million)
Table 33. Global RNA Synthesis Sales Value Share by Region (2021-2026)
Table 34. Global RNA Synthesis Sales Value by Region (2027-2032) & (US$ Million)
Table 35. Global RNA Synthesis Sales Value Share by Region (2027-2032)
Table 36. Global RNA Synthesis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global RNA Synthesis Sales Value by Country (2021-2026) & (US$ Million)
Table 38. Global RNA Synthesis Sales Value Market Share by Country (2021-2026)
Table 39. Global RNA Synthesis Sales Value by Country (2027-2032) & (US$ Million)
Table 40. Global RNA Synthesis Sales Value Market Share by Country (2027-2032)
Table 41. GenScript Company Information
Table 42. GenScript Business Overview
Table 43. GenScript RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. GenScript RNA Synthesis Product Portfolio
Table 45. GenScript Recent Development
Table 46. Hokkaido System Science Company Information
Table 47. Hokkaido System Science Business Overview
Table 48. Hokkaido System Science RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 49. Hokkaido System Science RNA Synthesis Product Portfolio
Table 50. Hokkaido System Science Recent Development
Table 51. Bio-Synthesis Company Information
Table 52. Bio-Synthesis Business Overview
Table 53. Bio-Synthesis RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 54. Bio-Synthesis RNA Synthesis Product Portfolio
Table 55. Bio-Synthesis Recent Development
Table 56. IDT Company Information
Table 57. IDT Business Overview
Table 58. IDT RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 59. IDT RNA Synthesis Product Portfolio
Table 60. IDT Recent Development
Table 61. Thermo Fisher Scientific Company Information
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 64. Thermo Fisher Scientific RNA Synthesis Product Portfolio
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Genewiz Company Information
Table 67. Genewiz Business Overview
Table 68. Genewiz RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 69. Genewiz RNA Synthesis Product Portfolio
Table 70. Genewiz Recent Development
Table 71. Gene Universal Company Information
Table 72. Gene Universal Business Overview
Table 73. Gene Universal RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Gene Universal RNA Synthesis Product Portfolio
Table 75. Gene Universal Recent Development
Table 76. TriLink BioTechnologies Company Information
Table 77. TriLink BioTechnologies Business Overview
Table 78. TriLink BioTechnologies RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 79. TriLink BioTechnologies RNA Synthesis Product Portfolio
Table 80. TriLink BioTechnologies Recent Development
Table 81. GE Healthcare Dharmacon Company Information
Table 82. GE Healthcare Dharmacon Business Overview
Table 83. GE Healthcare Dharmacon RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 84. GE Healthcare Dharmacon RNA Synthesis Product Portfolio
Table 85. GE Healthcare Dharmacon Recent Development
Table 86. ChemGenes Company Information
Table 87. ChemGenes Business Overview
Table 88. ChemGenes RNA Synthesis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. ChemGenes RNA Synthesis Product Portfolio
Table 90. ChemGenes Recent Development
Table 91. Creative Biolabs Company Information
Table 92. Creative Biolabs Business Overview
Table 93. Creative Biolabs RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 94. Creative Biolabs RNA Synthesis Product Portfolio
Table 95. Creative Biolabs Recent Development
Table 96. Glen Research Company Information
Table 97. Glen Research Business Overview
Table 98. Glen Research RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 99. Glen Research RNA Synthesis Product Portfolio
Table 100. Glen Research Recent Development
Table 101. VeliterBio Company Information
Table 102. VeliterBio Business Overview
Table 103. VeliterBio RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 104. VeliterBio RNA Synthesis Product Portfolio
Table 105. VeliterBio Recent Development
Table 106. Creative Biogene Company Information
Table 107. Creative Biogene Business Overview
Table 108. Creative Biogene RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 109. Creative Biogene RNA Synthesis Product Portfolio
Table 110. Creative Biogene Recent Development
Table 111. Merck Company Information
Table 112. Merck Business Overview
Table 113. Merck RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 114. Merck RNA Synthesis Product Portfolio
Table 115. Merck Recent Development
Table 116. Eurofins Scientific Company Information
Table 117. Eurofins Scientific Business Overview
Table 118. Eurofins Scientific RNA Synthesis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 119. Eurofins Scientific RNA Synthesis Product Portfolio
Table 120. Eurofins Scientific Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Authors List of This Report
Table 123. Secondary Sources
Table 124. Primary Sources
List of Figures
Figure 1. RNA Synthesis Product Image
Figure 2. Global RNA Synthesis Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global RNA Synthesis Market Size (2021-2032) & (US$ Million)
Figure 4. Global RNA Synthesis Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. mRNA Synthesis Image
Figure 8. tRNA Synthesis Image
Figure 9. rRNA Synthesis Image
Figure 10. siRNA Synthesis Image
Figure 11. Global RNA Synthesis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global RNA Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 13. Global RNA Synthesis Sales Value Share by Type (2021-2032)
Figure 14. Biomedical Science Image
Figure 15. Pharmaceutical Image
Figure 16. Others Image
Figure 17. Global RNA Synthesis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 18. Global RNA Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 19. Global RNA Synthesis Sales Value Share by Application (2021-2032)
Figure 20. Global RNA Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 21. Global RNA Synthesis Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 22. North America RNA Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 23. North America RNA Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Europe RNA Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 25. Europe RNA Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 26. Asia-Pacific RNA Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 27. Asia-Pacific RNA Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 28. South America RNA Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 29. South America RNA Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 30. Middle East & Africa RNA Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 31. Middle East & Africa RNA Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 32. USA RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. USA RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. USA RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Canada RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Canada RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Canada RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Mexico RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Mexico RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Mexico RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. Germany RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. Germany RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. Germany RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. France RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. France RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. France RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. U.K. RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. U.K. RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. U.K. RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Italy RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Italy RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Italy RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Spain RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Spain RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Spain RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Russia RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Russia RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Russia RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Netherlands RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Netherlands RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Netherlands RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. Nordic Countries RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. Nordic Countries RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. Nordic Countries RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. China RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. China RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. China RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. Japan RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. Japan RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. Japan RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. South Korea RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. South Korea RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. South Korea RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. India RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. India RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. India RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Australia RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Australia RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Australia RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Southeast Asia RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Southeast Asia RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Southeast Asia RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Brazil RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Brazil RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Brazil RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Argentina RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Argentina RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Argentina RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Chile RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Chile RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Chile RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Colombia RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Colombia RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Colombia RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Peru RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Peru RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Peru RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Saudi Arabia RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Saudi Arabia RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. Israel RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. Israel RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. Israel RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. UAE RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. UAE RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. UAE RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Turkey RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Turkey RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Turkey RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Iran RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Iran RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Iran RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Egypt RNA Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 114. Egypt RNA Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 115. Egypt RNA Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 116. Years Considered
Figure 117. Research Process
Figure 118. Key Executives Interviewed
Scope & coverage.
Types
- mRNA Synthesis
- tRNA Synthesis
- rRNA Synthesis
- siRNA Synthesis
Applications
- Biomedical Science
- Pharmaceutical
- Others
Companies covered
- GenScript
- Hokkaido System Science
- Bio-Synthesis
- IDT
- Thermo Fisher Scientific
- Genewiz
- Gene Universal
- TriLink BioTechnologies
- GE Healthcare Dharmacon
- ChemGenes
- Creative Biolabs
- Glen Research
- VeliterBio
- Creative Biogene
- Merck
- Eurofins Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global RNA Synthesis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global RNA Synthesis Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 RNA Synthesis Market Dynamics
- 2.1 RNA Synthesis Industry Trends
- 2.2 RNA Synthesis Industry Drivers
- 2.3 RNA Synthesis Industry Opportunities and Challenges
- 2.4 RNA Synthesis Industry Restraints
3 RNA Synthesis Market by Company
- 3.1 Global RNA Synthesis Company Revenue Ranking in 2025
- 3.2 Global RNA Synthesis Revenue by Company (2021-2026)
- 3.3 Global RNA Synthesis Company Ranking (2024-2026)
- 3.4 Global RNA Synthesis Company Manufacturing Base and Headquarters
- 3.5 Global RNA Synthesis Company Product Type and Application
- 3.6 Global RNA Synthesis Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global RNA Synthesis Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 RNA Synthesis Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 RNA Synthesis Market by Type
- 4.1 RNA Synthesis Type Introduction
- 4.1.1 mRNA Synthesis
- 4.1.2 tRNA Synthesis
- 4.1.3 rRNA Synthesis
- 4.1.4 siRNA Synthesis
- 4.2 Global RNA Synthesis Sales Value by Type
- 4.2.1 Global RNA Synthesis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global RNA Synthesis Sales Value by Type (2021-2032)
- 4.2.3 Global RNA Synthesis Sales Value Share by Type (2021-2032)
5 RNA Synthesis Market by Application
- 5.1 RNA Synthesis Application Introduction
- 5.1.1 Biomedical Science
- 5.1.2 Pharmaceutical
- 5.1.3 Others
- 5.2 Global RNA Synthesis Sales Value by Application
- 5.2.1 Global RNA Synthesis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global RNA Synthesis Sales Value by Application (2021-2032)
- 5.2.3 Global RNA Synthesis Sales Value Share by Application (2021-2032)
6 RNA Synthesis Regional Value Analysis
- 6.1 Global RNA Synthesis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global RNA Synthesis Sales Value by Region (2021-2032)
- 6.2.1 Global RNA Synthesis Sales Value by Region: 2021-2026
- 6.2.2 Global RNA Synthesis Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America RNA Synthesis Sales Value (2021-2032)
- 6.3.2 North America RNA Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe RNA Synthesis Sales Value (2021-2032)
- 6.4.2 Europe RNA Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific RNA Synthesis Sales Value (2021-2032)
- 6.5.2 Asia-Pacific RNA Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America RNA Synthesis Sales Value (2021-2032)
- 6.6.2 South America RNA Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa RNA Synthesis Sales Value (2021-2032)
- 6.7.2 Middle East & Africa RNA Synthesis Sales Value Share by Country, 2025 VS 2032
7 RNA Synthesis Country-level Value Analysis
- 7.1 Global RNA Synthesis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global RNA Synthesis Sales Value by Country (2021-2032)
- 7.2.1 Global RNA Synthesis Sales Value by Country (2021-2026)
- 7.2.2 Global RNA Synthesis Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.3.2 USA RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.7.2 France RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.14.2 China RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.17.2 India RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran RNA Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt RNA Synthesis Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt RNA Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt RNA Synthesis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 GenScript
- 8.1.1 GenScript Company Information
- 8.1.2 GenScript Business Overview
- 8.1.3 GenScript RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.1.4 GenScript RNA Synthesis Product Portfolio
- 8.1.5 GenScript Recent Developments
- 8.2 Hokkaido System Science
- 8.2.1 Hokkaido System Science Company Information
- 8.2.2 Hokkaido System Science Business Overview
- 8.2.3 Hokkaido System Science RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.2.4 Hokkaido System Science RNA Synthesis Product Portfolio
- 8.2.5 Hokkaido System Science Recent Developments
- 8.3 Bio-Synthesis
- 8.3.1 Bio-Synthesis Company Information
- 8.3.2 Bio-Synthesis Business Overview
- 8.3.3 Bio-Synthesis RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.3.4 Bio-Synthesis RNA Synthesis Product Portfolio
- 8.3.5 Bio-Synthesis Recent Developments
- 8.4 IDT
- 8.4.1 IDT Company Information
- 8.4.2 IDT Business Overview
- 8.4.3 IDT RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.4.4 IDT RNA Synthesis Product Portfolio
- 8.4.5 IDT Recent Developments
- 8.5 Thermo Fisher Scientific
- 8.5.1 Thermo Fisher Scientific Company Information
- 8.5.2 Thermo Fisher Scientific Business Overview
- 8.5.3 Thermo Fisher Scientific RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.5.4 Thermo Fisher Scientific RNA Synthesis Product Portfolio
- 8.5.5 Thermo Fisher Scientific Recent Developments
- 8.6 Genewiz
- 8.6.1 Genewiz Company Information
- 8.6.2 Genewiz Business Overview
- 8.6.3 Genewiz RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.6.4 Genewiz RNA Synthesis Product Portfolio
- 8.6.5 Genewiz Recent Developments
- 8.7 Gene Universal
- 8.7.1 Gene Universal Company Information
- 8.7.2 Gene Universal Business Overview
- 8.7.3 Gene Universal RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.7.4 Gene Universal RNA Synthesis Product Portfolio
- 8.7.5 Gene Universal Recent Developments
- 8.8 TriLink BioTechnologies
- 8.8.1 TriLink BioTechnologies Company Information
- 8.8.2 TriLink BioTechnologies Business Overview
- 8.8.3 TriLink BioTechnologies RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.8.4 TriLink BioTechnologies RNA Synthesis Product Portfolio
- 8.8.5 TriLink BioTechnologies Recent Developments
- 8.9 GE Healthcare Dharmacon
- 8.9.1 GE Healthcare Dharmacon Company Information
- 8.9.2 GE Healthcare Dharmacon Business Overview
- 8.9.3 GE Healthcare Dharmacon RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.9.4 GE Healthcare Dharmacon RNA Synthesis Product Portfolio
- 8.9.5 GE Healthcare Dharmacon Recent Developments
- 8.10 ChemGenes
- 8.10.1 ChemGenes Company Information
- 8.10.2 ChemGenes Business Overview
- 8.10.3 ChemGenes RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.10.4 ChemGenes RNA Synthesis Product Portfolio
- 8.10.5 ChemGenes Recent Developments
- 8.11 Creative Biolabs
- 8.11.1 Creative Biolabs Company Information
- 8.11.2 Creative Biolabs Business Overview
- 8.11.3 Creative Biolabs RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.11.4 Creative Biolabs RNA Synthesis Product Portfolio
- 8.11.5 Creative Biolabs Recent Developments
- 8.12 Glen Research
- 8.12.1 Glen Research Company Information
- 8.12.2 Glen Research Business Overview
- 8.12.3 Glen Research RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.12.4 Glen Research RNA Synthesis Product Portfolio
- 8.12.5 Glen Research Recent Developments
- 8.13 VeliterBio
- 8.13.1 VeliterBio Company Information
- 8.13.2 VeliterBio Business Overview
- 8.13.3 VeliterBio RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.13.4 VeliterBio RNA Synthesis Product Portfolio
- 8.13.5 VeliterBio Recent Developments
- 8.14 Creative Biogene
- 8.14.1 Creative Biogene Company Information
- 8.14.2 Creative Biogene Business Overview
- 8.14.3 Creative Biogene RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.14.4 Creative Biogene RNA Synthesis Product Portfolio
- 8.14.5 Creative Biogene Recent Developments
- 8.15 Merck
- 8.15.1 Merck Company Information
- 8.15.2 Merck Business Overview
- 8.15.3 Merck RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.15.4 Merck RNA Synthesis Product Portfolio
- 8.15.5 Merck Recent Developments
- 8.16 Eurofins Scientific
- 8.16.1 Eurofins Scientific Company Information
- 8.16.2 Eurofins Scientific Business Overview
- 8.16.3 Eurofins Scientific RNA Synthesis Revenue and Gross Margin (2021-2026)
- 8.16.4 Eurofins Scientific RNA Synthesis Product Portfolio
- 8.16.5 Eurofins Scientific Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst